Assemblyman Brian Maher (R,C-Walden) today announced his support for bipartisan legislation (A.3845A) sponsored by Assemblyman Patrick Burke to establish a state-administered psilocybin-assisted therapy pilot program for veterans, first responders and retired first responders.

The legislation would create a structured, federally compliant pilot program in partnership with State University of New York (SUNY) academic health centers, as well as a dedicated Psilocybin Assisted Therapy (P.A.T.) fund to support its implementation. The bill includes a $5 million appropriation and allows for philanthropic matching funds to maximize the use of resources.

Psilocybin-assisted therapy is an emerging treatment that uses a regulated psychedelic compound in a controlled clinical setting alongside professional mental health support. According to the National Center for Complementary and Integrative Health (NCCIH), psilocybin affects serotonin in the brain, altering mood and perception. Early research suggests it may help treat PTSD, depression and substance use disorders, particularly when traditional treatments have failed.

“New York is facing a growing mental health crisis, especially among those who have served our country and protect our communities,” said Meghan Hurlburt, chief of staff. “Too many veterans and first responders are struggling with PTSD, depression and addiction, and in many cases, existing treatments are not enough. This pilot program is about exploring innovative, evidence-based approaches that could provide real relief.”

This program positions New York to lead responsibly in this emerging field by leveraging partnerships with SUNY academic health centers that already possess clinical research infrastructure and experience with U.S. Food and Drug Administration- and Institutional Review Board-approved trials.

“By partnering with SUNY, the state can support the development of a trained clinical workforce, establish best practices and ensure that any future expansion of P.A.T. is grounded in rigorous data, patient safety and New York-specific standards,” added Hurlburt.

Mark A. Cozzupoli, director of Ulster County Veteran Services and chief master sergeant, USAF, said: “I applaud this bipartisan legislation because establishing a Psilocybin assisted Therapy Program is in the best interest of our veterans, first responders and their loved ones.It’s no secret that many veterans suffer from PTSD, substance abuse, and other mental health conditions, which can be attributed to their time in uniform.Assemblyman Maher and many others understand that it’s our responsibility to find creative treatment programs such as this, to help these heroes heal after the many sacrifices they made in the name of service.”

Supporters of the legislation emphasize that the pilot program is carefully designed to balance innovation with oversight. The inclusion of a dedicated fund and philanthropic matching component allows the state to advance cutting-edge treatment options without placing the full burden on taxpayers.

“This is a thoughtful, measured step forward,” Hurlburt said. “We owe it to our veterans and first responders to pursue every viable option that could improve their quality of life. This program allows us to do that in a safe, controlled and data-driven way.”

The bill represents a growing bipartisan effort to address the mental health challenges facing those who serve, while positioning New York as a leader in responsible clinical research and treatment innovation.